CN116212085A - A kind of preparation method of imitation skin dressing and imitation skin dressing - Google Patents
A kind of preparation method of imitation skin dressing and imitation skin dressing Download PDFInfo
- Publication number
- CN116212085A CN116212085A CN202310160576.3A CN202310160576A CN116212085A CN 116212085 A CN116212085 A CN 116212085A CN 202310160576 A CN202310160576 A CN 202310160576A CN 116212085 A CN116212085 A CN 116212085A
- Authority
- CN
- China
- Prior art keywords
- layer
- polyurethane
- skin dressing
- preparation
- imitation skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
- D01D5/0092—Electro-spinning characterised by the electro-spinning apparatus characterised by the electrical field, e.g. combined with a magnetic fields, using biased or alternating fields
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/40—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
- D04H1/42—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
- D04H1/4326—Condensation or reaction polymers
- D04H1/4358—Polyurethanes
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
- D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
- D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06C—FINISHING, DRESSING, TENTERING OR STRETCHING TEXTILE FABRICS
- D06C7/00—Heating or cooling textile fabrics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
- A61L2300/206—Biguanides, e.g. chlorohexidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Textile Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开了一种仿皮肤敷料的制备方法及仿皮肤敷料,其方法部分包括如下步骤:S1用于将阴离子型水性聚氨酯纺丝液和阳离子型水性聚氨酯纺丝液按不同比重采用静电纺丝工艺制备成聚氨酯层的步骤;S2用于对聚氨酯层采用热处理工艺进行热处理的步骤。S3用于将抗菌层贴合到热处理后的聚氨酯层的步骤;S4用于将创面接触层贴合到抗菌层的步骤。本发明所公开的仿皮肤敷料的制备方法及仿皮肤敷料,呈现出仿皮肤一样的褶皱外观,使得聚氨酯层具备高延展性、高弹性和回复性,能达到与关节部位的动态贴合。
The invention discloses a preparation method of an imitation skin dressing and the imitation skin dressing. The method part includes the following steps: S1 is used to electrospin the anionic water-based polyurethane spinning solution and the cationic water-based polyurethane spinning solution according to different specific gravity The process is a step of preparing a polyurethane layer; S2 is a step of heat-treating the polyurethane layer using a heat treatment process. S3 is used for the step of attaching the antibacterial layer to the heat-treated polyurethane layer; S4 is used for the step of attaching the wound surface contact layer to the antibacterial layer. The preparation method of the imitation skin dressing and the imitation skin dressing disclosed in the present invention have the same wrinkled appearance as the imitation skin, so that the polyurethane layer has high ductility, high elasticity and resilience, and can achieve dynamic fit with joints.
Description
技术领域technical field
本发明涉及医用敷料技术领域,尤其涉及一种仿皮肤敷料的制备方法及仿皮肤敷料。The invention relates to the technical field of medical dressings, in particular to a preparation method of an imitation skin dressing and the imitation skin dressing.
背景技术Background technique
人体皮肤柔软有很好的延展性,尤其是关节部位,皮肤伸长率超过50%。皮肤中存在大量的胶原蛋白,胶原蛋白作为一种细胞外蛋白质,在伤口愈合过程的不同阶段发挥着重要作用,其与细胞的增殖、分化、迁移等密切相关。Human skin is soft and has good extensibility, especially in joints, where the skin elongation rate exceeds 50%. There is a large amount of collagen in the skin. Collagen, as an extracellular protein, plays an important role in different stages of the wound healing process, and is closely related to cell proliferation, differentiation, and migration.
目前市面已有的敷料产品,包括背衬和敷芯,一般背衬表面结构平整,拉伸长度有限,导致敷料弹性较差,无法实现与关节部位的动态贴合。Currently, the existing dressing products on the market, including backing and core application, generally have a flat surface structure and limited stretching length, resulting in poor elasticity of the dressing, which cannot achieve dynamic fit with joints.
发明内容Contents of the invention
本发明的目的是提供一种仿皮肤敷料的制备方法及仿皮肤敷料。The purpose of the present invention is to provide a preparation method of an imitation skin dressing and an imitation skin dressing.
本发明所提供的仿皮肤敷料的制备方法,包括如下步骤:The preparation method of imitation skin dressing provided by the present invention may further comprise the steps:
S1用于将阴离子型水性聚氨酯纺丝液和阳离子型水性聚氨酯纺丝液按不同比重采用静电纺丝工艺制备成聚氨酯层的步骤;S1 is used to prepare the anionic water-based polyurethane spinning solution and the cationic water-based polyurethane spinning solution into a polyurethane layer by using an electrospinning process according to different specific gravity;
S2用于对聚氨酯层采用热处理工艺进行热处理的步骤。S2 is a step of heat-treating the polyurethane layer using a heat-treatment process.
S3用于将抗菌层贴合到热处理后的聚氨酯层的步骤;S3 is used for the step of bonding antibacterial layer to the polyurethane layer after heat treatment;
S4用于将创面接触层贴合到抗菌层的步骤。S4 is a step of attaching the wound contact layer to the antibacterial layer.
优选的,所述阴离子型水性聚氨酯纺丝液由占比为10-25%的阴离子型水性氨酯、占比为0.5-5%的交联剂和溶剂混合制成。Preferably, the anionic water-based polyurethane spinning solution is prepared by mixing anionic water-based urethane accounting for 10-25%, cross-linking agent accounting for 0.5-5%, and a solvent.
优选的,所述阳离子型水性聚氨酯纺丝液由占比为10-25%的阳离子型水性氨酯、占比为0.5-5%的交联剂、占比为2-10%的疏水剂和溶剂混合制成。Preferably, the cationic water-based polyurethane spinning solution is composed of cationic water-based urethane accounting for 10-25%, cross-linking agent accounting for 0.5-5%, hydrophobic agent accounting for 2-10% and Solvent blends are made.
优选的,所述溶剂为二甲基甲酰胺、乙醇、水或二甲基亚砜中的一种;所述交联剂为聚碳化二亚胺、氮丙啶、异氰酸酯或环氧硅烷中的一种;所述疏水剂为聚硅氧烷、硅烷偶联剂或无氟丙烯酸中的一种。Preferably, the solvent is one of dimethylformamide, ethanol, water or dimethyl sulfoxide; the crosslinking agent is polycarbodiimide, aziridine, isocyanate or epoxy silane One; the hydrophobic agent is one of polysiloxane, silane coupling agent or fluorine-free acrylic acid.
优选的,所述阴离子型水性聚氨酯纺丝液和所述阳离子型水性聚氨酯纺丝液的配种比为6:4、5:5或4:6。本领域技术人员可以理解,可以根据具体需求采用不用比重的配比方式,从而制得所需延展性或支撑性要求的聚氨酯层。Preferably, the mixing ratio of the anionic aqueous polyurethane spinning solution to the cationic aqueous polyurethane spinning solution is 6:4, 5:5 or 4:6. Those skilled in the art can understand that the proportioning method without specific gravity can be used according to specific requirements, so as to obtain the polyurethane layer with the required ductility or support requirements.
优选的,所述S1用于将阴离子型水性聚氨酯纺丝液和阳离子型水性聚氨酯纺丝液按不同比重采用静电纺丝工艺制备成聚氨酯层的步骤,包括:Preferably, said S1 is used for the step of preparing an anionic water-based polyurethane spinning solution and a cationic water-based polyurethane spinning solution into a polyurethane layer by an electrospinning process according to different specific gravity, including:
S21采用纺丝电压:10-30kV,接收距离:10-15cm,灌注速度:0.6-2mL/h,温度10-30℃,相对湿度:25-70%的环境下,分别使用三个针筒对阴离子型水性聚氨酯纺丝液和阳离子型水性聚氨酯纺丝液进行并排纺丝,通过改变灌注速度来实施纺丝液的不同配比的步骤。S22每定时1-2个小时,对灌注不同水性氨酯纺丝液的针筒进行位置互换,继续进行纺丝,制得聚氨酯层的步骤。S21 adopts spinning voltage: 10-30kV, receiving distance: 10-15cm, perfusion speed: 0.6-2mL/h, temperature 10-30℃, relative humidity: 25-70%, use three syringe pairs respectively The anionic water-based polyurethane spinning solution and the cationic water-based polyurethane spinning solution are spun side by side, and the steps of different ratios of the spinning solution are implemented by changing the infusion speed. S22: The step of exchanging the positions of the syringes filled with different water-based urethane spinning solutions every 1-2 hours at regular intervals, and continuing spinning to obtain a polyurethane layer.
优选的,所述抗菌层由含有CHG(葡萄糖酸氯己定)、PHMB(聚六亚甲基双胍盐酸盐)和银离子的亲水聚氨酯泡棉制成。Preferably, the antibacterial layer is made of hydrophilic polyurethane foam containing CHG (chlorhexidine gluconate), PHMB (polyhexamethylene biguanide hydrochloride) and silver ions.
优选的,所述热处理工艺为采用真空烘箱,调整其加热温度为40-80℃,压强为10-101kPa,对聚氨酯层进行加热10-120分钟。Preferably, the heat treatment process is to use a vacuum oven, adjust the heating temperature to 40-80° C., and adjust the pressure to 10-101 kPa to heat the polyurethane layer for 10-120 minutes.
优选的,所述创面接触层为占比25-30%的胶原蛋白、占比15-20%的乙酸和溶剂混合后进行静电纺丝工艺制成。Preferably, the wound contact layer is made by mixing collagen accounting for 25-30%, acetic acid accounting for 15-20%, and a solvent, followed by electrospinning.
优选的,所述创面接触层采用胶原蛋白纳米纤维或者明胶纳米纤维制成。Preferably, the wound contact layer is made of collagen nanofibers or gelatin nanofibers.
本发明所提供的仿皮肤敷料,包括聚氨酯层(1)和抗菌层(2);所述抗菌层(2)贴合在所述聚氨酯层(1)的一侧;所述聚氨酯层(1)具有不规则的褶皱结构。The imitation skin dressing provided by the present invention comprises a polyurethane layer (1) and an antibacterial layer (2); the antibacterial layer (2) is attached to one side of the polyurethane layer (1); the polyurethane layer (1) Has an irregular wrinkled structure.
优选的,所述褶皱结构为不规则排列的间隔设置。Preferably, the pleated structures are irregularly arranged at intervals.
优选的,本发明所提供的仿皮肤敷料,还包括一胶粘层(3);所述胶粘层(3)的尺寸与所述聚氨酯层(1)的尺寸相同。Preferably, the imitation skin dressing provided by the present invention further includes an adhesive layer (3); the size of the adhesive layer (3) is the same as that of the polyurethane layer (1).
优选的,本发明所提供的仿皮肤敷料,还包括一创面接触层(4);所述创面接触层(4)贴合在所述胶粘层(3)远离所述抗菌层(2)的一侧。Preferably, the imitation skin dressing provided by the present invention also includes a wound contact layer (4); side.
优选的,所述创面接触层(4)的尺寸与所述抗菌层(2)的尺寸相同。Preferably, the size of the wound contact layer (4) is the same as that of the antibacterial layer (2).
本发明所提供的一种仿皮肤敷料的制备方法及仿皮肤敷料,呈现出仿皮肤一样的褶皱结构,使得聚氨酯层具备高延展性、高弹性和回复性,使得敷料能达到与关节部位的动态贴合。The preparation method of a skin-like dressing and the skin-like dressing provided by the present invention present a skin-like wrinkle structure, so that the polyurethane layer has high ductility, high elasticity and recovery, so that the dressing can achieve dynamic contact with joints. fit.
附图说明Description of drawings
图1本发明实施例一所述的仿皮肤敷料的制备方法的流程示意图;Fig. 1 is a schematic flow diagram of the preparation method of the imitation skin dressing described in
图2为本发明实施例二所述的仿皮肤敷料的剖面结构示意图;Fig. 2 is a schematic cross-sectional structure diagram of the imitation skin dressing described in
图3为本发明实施例二所述的聚氨酯层的俯视结构示意图。FIG. 3 is a schematic top view of the polyurethane layer described in
具体实施方式Detailed ways
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments It is a part of embodiments of the present invention, but not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
实施例一Embodiment one
如图1-3所示,本实施例所提供的仿皮肤敷料的制备方法,包括如下步骤:As shown in Figure 1-3, the preparation method of the imitation skin dressing provided by the present embodiment comprises the following steps:
S1用于将阴离子型水性聚氨酯纺丝液和阳离子型水性聚氨酯纺丝液按不同比重采用静电纺丝工艺制备成聚氨酯层的步骤;S1 is used to prepare the anionic water-based polyurethane spinning solution and the cationic water-based polyurethane spinning solution into a polyurethane layer by using an electrospinning process according to different specific gravity;
S2用于对聚氨酯层采用热处理工艺进行热处理的步骤。S2 is a step of heat-treating the polyurethane layer using a heat-treatment process.
S3用于将抗菌层贴合到热处理后的聚氨酯层的步骤;S3 is used for the step of bonding antibacterial layer to the polyurethane layer after heat treatment;
S4用于将创面接触层贴合到抗菌层的步骤。S4 is a step of attaching the wound contact layer to the antibacterial layer.
本领域技术人员可以理解,通过对聚氨酯层进行热处理,由于聚氨酯层中阴离子型水性氨酯纳米纤维和阳离子型水性氨酯纳米纤维收缩率不同,在无张力状态下,二者会呈现不同的收缩比,二者互相制约,使得本实施例所提供的仿皮肤敷料呈现出仿皮肤一样的褶皱结构,使得聚氨酯层具备高延展性、高弹性和回复性,能达到与关节部位的动态贴合。Those skilled in the art can understand that by heat-treating the polyurethane layer, due to the different shrinkage rates of anionic water-based urethane nanofibers and cationic water-based urethane nanofibers in the polyurethane layer, the two will show different shrinkages in a tension-free state. Compared with each other, the two restrict each other, so that the skin-like dressing provided in this embodiment presents a wrinkled structure like skin-like, so that the polyurethane layer has high ductility, high elasticity and recovery, and can achieve dynamic fit with joints.
进一步,所述阴离子型水性聚氨酯纺丝液由占比为10-25%的阴离子型水性氨酯、占比为0.5-5%的交联剂和溶剂混合制成。Further, the anionic water-based polyurethane spinning solution is prepared by mixing anionic water-based urethane accounting for 10-25%, cross-linking agent accounting for 0.5-5%, and solvent.
进一步,所述阳离子型水性聚氨酯纺丝液由占比为10-25%的阳离子型水性氨酯、占比为0.5-5%的交联剂、占比为2-10%的疏水剂和溶剂混合制成。Further, the cationic water-based polyurethane spinning solution is composed of cationic water-based urethane accounting for 10-25%, cross-linking agent accounting for 0.5-5%, hydrophobic agent and solvent accounting for 2-10% Mix made.
进一步,所述溶剂为二甲基甲酰胺、乙醇、水或二甲基亚砜中的一种;所述交联剂为聚碳化二亚胺、氮丙啶、异氰酸酯或环氧硅烷中的一种;所述疏水剂为聚硅氧烷、硅烷偶联剂或无氟丙烯酸中的一种。Further, the solvent is one of dimethylformamide, ethanol, water or dimethyl sulfoxide; the crosslinking agent is one of polycarbodiimide, aziridine, isocyanate or epoxy silane species; the hydrophobic agent is one of polysiloxane, silane coupling agent or fluorine-free acrylic acid.
进一步,所述阴离子型水性聚氨酯纺丝液和所述阳离子型水性聚氨酯纺丝液的配种比为6:4、5:5或4:6。本领域技术人员可以理解,可以根据具体需求采用不用比重的配比方式,从而制得所需延展性或支撑性要求的聚氨酯层。Further, the compounding ratio of the anionic water-based polyurethane spinning solution to the cationic water-based polyurethane spinning solution is 6:4, 5:5 or 4:6. Those skilled in the art can understand that the proportioning method without specific gravity can be used according to specific requirements, so as to obtain the polyurethane layer with the required ductility or support requirements.
进一步,所述S1用于将阴离子型水性聚氨酯纺丝液和阳离子型水性聚氨酯纺丝液按不同比重采用静电纺丝工艺制备成聚氨酯层的步骤,包括:Further, said S1 is used to prepare the anionic water-based polyurethane spinning solution and the cationic water-based polyurethane spinning solution into a polyurethane layer by electrospinning process according to different specific gravity, including:
S21采用纺丝电压:10-30kV,接收距离:10-15cm,灌注速度:0.6-2mL/h,温度10-30℃,相对湿度:25-70%的环境下,分别使用三个针筒对阴离子型水性聚氨酯纺丝液和阳离子型水性聚氨酯纺丝液进行并排纺丝,通过改变灌注速度来实施纺丝液的不同配比的步骤。S21 adopts spinning voltage: 10-30kV, receiving distance: 10-15cm, perfusion speed: 0.6-2mL/h, temperature 10-30℃, relative humidity: 25-70%, use three syringe pairs respectively The anionic water-based polyurethane spinning solution and the cationic water-based polyurethane spinning solution are spun side by side, and the steps of different ratios of the spinning solution are implemented by changing the infusion speed.
S22每定时1-2个小时,对灌注不同水性氨酯的针筒进行位置互换,继续进行纺丝,制得聚氨酯层的步骤。S22 The step of exchanging the positions of the syringes filled with different water-based polyurethanes every 1-2 hours at regular intervals, continuing spinning, and preparing the polyurethane layer.
本领域技术人员可以理解,通过定时互换位置进行纺丝,可提高聚氨酯层的仿皮肤性。Those skilled in the art can understand that the skin-like property of the polyurethane layer can be improved by regularly exchanging positions for spinning.
进一步,所述抗菌层由含有CHG(葡萄糖酸氯己定)、PHMB(聚六亚甲基双胍盐酸盐)和银离子的亲水聚氨酯泡棉制成。本领域技术人员可以理解,抗菌层是含有抗菌药物(CHG、PHMB、银离子等)的亲水聚氨酯泡棉,用来吸收伤口渗液,同时对吸收的液体中微生物进行管理。Further, the antibacterial layer is made of hydrophilic polyurethane foam containing CHG (chlorhexidine gluconate), PHMB (polyhexamethylene biguanide hydrochloride) and silver ions. Those skilled in the art can understand that the antibacterial layer is a hydrophilic polyurethane foam containing antibacterial drugs (CHG, PHMB, silver ions, etc.), which is used to absorb wound exudate and manage microorganisms in the absorbed liquid.
进一步,所述热处理工艺为采用真空烘箱,调整其加热温度为40-80℃,压强为10-101kPa,对聚氨酯层进行加热10-120分钟。本领域技术人员可以理解,聚氨酯层内的两种氨酯材料收缩率不同,在纤维膜上呈现褶皱。Further, the heat treatment process is to use a vacuum oven, adjust the heating temperature to 40-80° C., and adjust the pressure to 10-101 kPa to heat the polyurethane layer for 10-120 minutes. Those skilled in the art can understand that the shrinkage rates of the two polyurethane materials in the polyurethane layer are different, and wrinkles appear on the fiber membrane.
进一步,所述创面接触层为占比25-30%的胶原蛋白、占比15-20%的乙酸和溶剂混合后进行静电纺丝工艺制成。本领域技术人员可以理解,创面接触层的静电纺丝条件采用纺丝电压:10-30kV,接收距离:15-20cm,灌注速度:1-4mL/h,温度20-30℃,相对湿度:25-70%。胶原蛋白为胶原或明胶。Further, the wound contact layer is made by mixing collagen accounting for 25-30%, acetic acid accounting for 15-20%, and a solvent, followed by electrospinning. Those skilled in the art can understand that the electrospinning conditions of the wound surface contact layer adopt spinning voltage: 10-30kV, receiving distance: 15-20cm, perfusion speed: 1-4mL/h, temperature 20-30°C, relative humidity: 25 -70%. Collagen is collagen or gelatin.
进一步,所述创面接触层采用胶原蛋白纳米纤维或者明胶纳米纤维制成。本领域技术人员可以理解,创面接触层模拟天然细胞外基质,空隙结构有利于细胞黏附成长,敷料能从原料、结构两方面仿天然皮肤组织结构,能促进细胞成活与生长。Further, the wound contact layer is made of collagen nanofibers or gelatin nanofibers. Those skilled in the art can understand that the wound contact layer simulates the natural extracellular matrix, and the void structure is conducive to cell adhesion and growth. The dressing can imitate the natural skin tissue structure in terms of raw materials and structure, and can promote cell survival and growth.
实施例二Embodiment two
本实施例所提供的仿皮肤敷料,包括聚氨酯层1和抗菌层2;所述抗菌层2贴合在所述聚氨酯层1的一侧;所述聚氨酯层1呈褶皱结构。本领域技术人员可以理解,本实施例所提供的仿皮肤敷料呈现出仿皮肤一样的褶皱外观,使得聚氨酯层1具备高延展性、高弹性和回复性,能达到与关节部位的动态贴合。The imitation skin dressing provided in this embodiment includes a
本领域技术人员可以理解,所述聚氨酯层由阴离子型水性聚氨酯纺丝液和阳离子型水性聚氨酯纺丝液按不同比重采用静电纺丝制成,通过对聚氨酯层进行热处理,由于聚氨酯层中阴离子型水性氨酯和阳离子型水性氨酯收缩率不同,在无张力状态下,二者会呈现不同的收缩比,二者互相制约,使得本实施例所提供的仿皮肤敷料呈现出仿皮肤一样的褶皱结构。Those skilled in the art can understand that the polyurethane layer is made of anionic water-based polyurethane spinning solution and cationic water-based polyurethane spinning solution according to different specific gravity by electrospinning. Water-based urethane and cationic water-based urethane have different shrinkage ratios. In the tension-free state, the two will show different shrinkage ratios. The two restrict each other, so that the skin-like dressing provided in this embodiment presents skin-like folds structure.
本领域技术人员可以理解,阴离子型水性聚氨酯纺丝液由占比为10-25%的阴离子型水性氨酯、占比为0.5-5%的交联剂和溶剂混合制成。所述阳离子型水性聚氨酯纺丝液由占比为10-25%的阳离子型水性氨酯、占比为0.5-5%的交联剂、占比为2-10%的疏水剂和溶剂混合制成。所述溶剂为二甲基甲酰胺、乙醇、水或二甲基亚砜中的一种;所述交联剂为聚碳化二亚胺、氮丙啶、异氰酸酯或环氧硅烷中的一种;所述疏水剂为聚硅氧烷、硅烷偶联剂或无氟丙烯酸中的一种。所述阴离子型水性聚氨酯纺丝液和所述阳离子型水性聚氨酯纺丝液的配种比为6:4、5:5或4:6。本领域技术人员可以理解,可以根据具体需求采用不用比重的配比方式,从而制得所需延展性或支撑性要求的聚氨酯层。Those skilled in the art can understand that the anionic water-based polyurethane spinning solution is prepared by mixing anionic water-based urethane accounting for 10-25%, cross-linking agent and solvent accounting for 0.5-5%. The cationic water-based polyurethane spinning solution is prepared by mixing cationic water-based urethane accounting for 10-25%, cross-linking agent accounting for 0.5-5%, hydrophobic agent accounting for 2-10%, and solvent. become. The solvent is one of dimethylformamide, ethanol, water or dimethyl sulfoxide; the crosslinking agent is one of polycarbodiimide, aziridine, isocyanate or epoxy silane; The hydrophobic agent is one of polysiloxane, silane coupling agent or fluorine-free acrylic acid. The mixing ratio of the anionic water-based polyurethane spinning solution to the cationic water-based polyurethane spinning solution is 6:4, 5:5 or 4:6. Those skilled in the art can understand that the proportioning method without specific gravity can be used according to specific requirements, so as to obtain the polyurethane layer with the required ductility or support requirements.
本领域技术人员可以理解,所述抗菌层2由含有CHG葡萄糖酸氯己定、PHMB聚六亚甲基双胍盐酸盐和银离子的亲水聚氨酯泡棉制成,亲水聚氨酯泡棉用来吸收伤口渗液,其含有的CHG、PHMB和银离子同时对吸收的液体中微生物进行管理。Those skilled in the art will understand that the
进一步,所述褶皱结构为不规则排列的间隔设置。Further, the wrinkle structure is irregularly arranged at intervals.
进一步,本实施例所提供的仿皮肤敷料,还包括一胶粘层3;所述胶粘层3的尺寸与所述聚氨酯层1的尺寸相同。本领域技术人员可以理解,通过胶粘层3贴合在抗菌层2和聚氨酯层1上,将本实施例所提供的仿皮肤敷料固定在伤口上。Further, the imitation skin dressing provided in this embodiment also includes an adhesive layer 3 ; the size of the adhesive layer 3 is the same as that of the
进一步,本实施例所提供的仿皮肤敷料,还包括一创面接触层4;所述创面接触层4贴合在所述胶粘层3远离所述抗菌层2的一侧。本领域技术人员可以理解,所述创面接触层4为占比25-30%的胶原蛋白、占比15-20%的乙酸和溶剂混合后进行静电纺丝工艺制成。胶原蛋白为胶原或明胶,创面接触层4是胶原蛋白纳米纤维或明胶纳米纤维,模拟天然细胞外基质,空隙结构有利于细胞黏附生长,敷料能从原料和结构两方面仿天然皮肤组织结构,能促进细胞成活与生长。Further, the imitation skin dressing provided in this embodiment also includes a
进一步,所述创面接触层4的尺寸与所述抗菌层2的尺寸相同。本领域技术人员可以理解,创面接触层4尺寸过大,将会与聚氨酯层相粘合,导致聚氨酯层与皮肤的贴合面减少会影响敷料的粘贴效果,也提高了用料增加了企业成本;尺寸过小,起不到良好的促进伤口愈合的效果。Further, the size of the
最后应说明的是:以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。Finally, it should be noted that: the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: it can still be Modifications are made to the technical solutions described in the foregoing embodiments, or equivalent replacements are made to some of the technical features; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the spirit and scope of the technical solutions of the various embodiments of the present invention.
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310160576.3A CN116212085B (en) | 2023-02-23 | 2023-02-23 | A preparation method of imitation skin dressing and imitation skin dressing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310160576.3A CN116212085B (en) | 2023-02-23 | 2023-02-23 | A preparation method of imitation skin dressing and imitation skin dressing |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116212085A true CN116212085A (en) | 2023-06-06 |
CN116212085B CN116212085B (en) | 2024-12-20 |
Family
ID=86590596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310160576.3A Active CN116212085B (en) | 2023-02-23 | 2023-02-23 | A preparation method of imitation skin dressing and imitation skin dressing |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116212085B (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4600001A (en) * | 1984-08-15 | 1986-07-15 | The Kendall Company | Combined wound dressing and delivery means composite |
CN104540669A (en) * | 2012-07-18 | 2015-04-22 | 格拉德产品公司 | Multi-ply puckered films formed by discontinous lamination of films having different rebound ratios |
CN110841102A (en) * | 2019-11-29 | 2020-02-28 | 青岛农业大学 | Composite nanofiber elastic bandage and preparation method thereof |
CN111068097A (en) * | 2020-01-08 | 2020-04-28 | 河南亚都实业有限公司 | Sterilizing and anti-inflammatory wound repair dressing and preparation method thereof |
CN111214962A (en) * | 2019-12-10 | 2020-06-02 | 中国科学院过程工程研究所 | A kind of wrinkled graphene oxide/nanofiber composite membrane and its preparation method and application |
CN111575904A (en) * | 2020-05-21 | 2020-08-25 | 东华大学 | Super-elastic waterproof breathable skin dressing with folded structure and preparation method thereof |
CN114225093A (en) * | 2021-12-22 | 2022-03-25 | 振德医疗用品股份有限公司 | Antibacterial dressing with composite function and preparation method thereof |
DE102022112586A1 (en) * | 2022-05-19 | 2022-07-14 | Carl Freudenberg Kg | wound dressing |
CN219375587U (en) * | 2023-02-23 | 2023-07-21 | 上海亚澳医用保健品有限公司 | Skin-imitated dressing |
CN118547428A (en) * | 2024-05-23 | 2024-08-27 | 东华大学 | A body temperature induced heat shrinkable fiber dressing and its preparation and application |
-
2023
- 2023-02-23 CN CN202310160576.3A patent/CN116212085B/en active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4600001A (en) * | 1984-08-15 | 1986-07-15 | The Kendall Company | Combined wound dressing and delivery means composite |
CN104540669A (en) * | 2012-07-18 | 2015-04-22 | 格拉德产品公司 | Multi-ply puckered films formed by discontinous lamination of films having different rebound ratios |
CN110841102A (en) * | 2019-11-29 | 2020-02-28 | 青岛农业大学 | Composite nanofiber elastic bandage and preparation method thereof |
CN111214962A (en) * | 2019-12-10 | 2020-06-02 | 中国科学院过程工程研究所 | A kind of wrinkled graphene oxide/nanofiber composite membrane and its preparation method and application |
CN111068097A (en) * | 2020-01-08 | 2020-04-28 | 河南亚都实业有限公司 | Sterilizing and anti-inflammatory wound repair dressing and preparation method thereof |
CN111575904A (en) * | 2020-05-21 | 2020-08-25 | 东华大学 | Super-elastic waterproof breathable skin dressing with folded structure and preparation method thereof |
CN114225093A (en) * | 2021-12-22 | 2022-03-25 | 振德医疗用品股份有限公司 | Antibacterial dressing with composite function and preparation method thereof |
DE102022112586A1 (en) * | 2022-05-19 | 2022-07-14 | Carl Freudenberg Kg | wound dressing |
CN219375587U (en) * | 2023-02-23 | 2023-07-21 | 上海亚澳医用保健品有限公司 | Skin-imitated dressing |
CN118547428A (en) * | 2024-05-23 | 2024-08-27 | 东华大学 | A body temperature induced heat shrinkable fiber dressing and its preparation and application |
Non-Patent Citations (1)
Title |
---|
ZHANG KEYAN等: "Bioinspired sequentially crosslinked nanofibrous hydrogels with robust adhesive and stretchable capability for joint wound dressing", COMPOSITES COMMUNICATIONS, vol. 26, 31 August 2021 (2021-08-31), pages 100785 * |
Also Published As
Publication number | Publication date |
---|---|
CN116212085B (en) | 2024-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111588900B (en) | Waterproof, breathable, high-elasticity, self-repairing double-layer nanofiber membrane for skin dressing and its preparation method | |
CN107693835B (en) | Polyvinyl alcohol/collagen/quaternized chitosan electrostatic spinning composite fiber film and preparation method thereof | |
CN110302432A (en) | Preparation method of full-thickness skin tissue engineering scaffold with gradient pore structure | |
CN114225088A (en) | A kind of composite multi-layer dressing and its preparation method and application | |
CN105696352A (en) | A kind of silicon wool product and preparation method thereof | |
CN109481148B (en) | A kind of moisture absorption vapor-permeable type wound dressing patch | |
CN113368295A (en) | Preparation method of antibacterial large-deformation customized dressing capable of directionally discharging seepage | |
CN107496972A (en) | A kind of moist dressing and preparation method thereof that prevents adhesion for promoting burn wound healing | |
CN110338867A (en) | Electrostatic spinning Wound dressing and its processing method containing dihydroquercetin | |
CN110791950A (en) | Method for preparing soluble hemostatic textile material | |
CN116212085A (en) | A kind of preparation method of imitation skin dressing and imitation skin dressing | |
CN112853623A (en) | Preparation method of electrospun kaolinite reinforced natural polysaccharide porous fiber membrane | |
CN219375587U (en) | Skin-imitated dressing | |
CN113846419B (en) | Antibacterial and disinfectant nanofiber medical dressing and preparation method thereof | |
CN213250395U (en) | Alginate dressing | |
CN211798243U (en) | Microneedle patch | |
CN109498271B (en) | Directional liquid-absorbing anti-adhesion gauze and manufacturing method thereof | |
CN109289078B (en) | Long-acting antibacterial band-aid | |
CN203694184U (en) | Biofiber Composite Dressing | |
CN108498842B (en) | Medical dressing for in vitro wound care and preparation method thereof | |
CN207101546U (en) | A kind of electret Silica hydrogel for scar repairing | |
CN117065075A (en) | Nanofiber antibacterial dressing and preparation method thereof | |
CN110403920B (en) | Disposable medical hydrogel eye patch | |
CN115845114A (en) | Nanofiber medical wound dressing and preparation method thereof | |
CN114452081A (en) | Rapid hemostasis application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |